July 22, 2014 3:56 PM ET

Pharmaceuticals

Company Overview of Jennerex Biotherapeutics, Inc.

Executive Profile

John Bell Ph.D.

Chief Scientific Officer and Director, Jennerex Biotherapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

John Bell, PhD, serves as the Chief Scientific Officer at Jennerex Biotherapeutics, Inc. Dr. Bell serves as a Senior Scientist at the Ottawa Health Research Institute. In 1986, he began his independent research career at McGill University in the Department of Biochemistry supported by a Medical Research Council Scholarship and subsequently as a Senior Scientist of the National Cancer Institute of Canada. Dr. Bell moved to the Department of Medicine at the University ...

Corporate Headquarters

450 Sansome Street
San Francisco, California 94111

United States

Phone: 415-281-8886
Fax: --

Board Members Memberships

Chief Scientific Officer and Director

Education

PhD
McMaster University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Jennerex Biotherapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.